TreeWAS – Variant ID: rs10927094

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z92.4 Personal history of major surgery, not elsewhere classified	0.000	0.959	0.041
C83.3 Large cell (diffuse)	0.014	0.986	0.000
C92 Myeloid leukaemia	0.014	0.986	0.000
C92.1 Chronic myeloid leukaemia	0.013	0.986	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.013	0.987	0.000
K04.7 Periapical abscess without sinus	0.013	0.987	0.000
C92.0 Acute myeloid leukaemia	0.013	0.987	0.000
C92.7 Other myeloid leukaemia	0.012	0.988	0.000
C83.1 Small cleaved cell (diffuse)	0.012	0.988	0.000
C92.4 Acute promyelocytic leukaemia	0.012	0.988	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.012	0.988	0.000
B37.8 Candidiasis of other sites	0.000	0.989	0.011
C91 Lymphoid leukaemia	0.011	0.989	0.000
C91.4 Hairy-cell leukaemia	0.011	0.989	0.000
E05.9 Thyrotoxicosis, unspecified	0.011	0.989	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.010	0.990	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.010	0.990	0.000
C92.5 Acute myelomonocytic leukaemia	0.010	0.990	0.000
C92.3 Myeloid sarcoma	0.010	0.990	0.000
C92.2 Subacute myeloid leukaemia	0.010	0.990	0.000
C83.7 Burkitt's tumour	0.010	0.990	0.000
C93 Monocytic leukaemia	0.010	0.990	0.000
C92.9 Myeloid leukaemia, unspecified	0.010	0.990	0.000
C91.5 Adult T-cell leukaemia	0.010	0.990	0.000
C83.6 Undifferentiated (diffuse)	0.009	0.990	0.000
C83.5 Lymphoblastic (diffuse)	0.009	0.990	0.000
C83.4 Immunoblastic (diffuse)	0.009	0.990	0.000
C83.2 Mixed small and large cell (diffuse)	0.009	0.990	0.000
C86 Other specified types of T/NK-cell lymphoma	0.009	0.991	0.000
C95 Leukaemia of unspecified cell type	0.009	0.991	0.000
C85.1 B-cell lymphoma, unspecified	0.009	0.991	0.000
C93.1 Chronic monocytic leukaemia	0.009	0.991	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.009	0.991	0.000
C94 Other leukaemias of specified cell type	0.009	0.991	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.008	0.992	0.000
C91.0 Acute lymphoblastic leukaemia	0.008	0.992	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.008	0.992	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.008	0.992	0.000
C91.7 Other lymphoid leukaemia	0.008	0.992	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.008	0.992	0.000
C91.3 Prolymphocytic leukaemia	0.008	0.992	0.000
C91.2 Subacute lymphocytic leukaemia	0.008	0.992	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.008	0.992	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.008	0.992	0.000
C91.9 Lymphoid leukaemia, unspecified	0.008	0.992	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.008	0.992	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.008	0.992	0.000
C81 Hodgkin's disease	0.008	0.992	0.000
C93.9 Monocytic leukaemia, unspecified	0.007	0.993	0.000
C93.7 Other monocytic leukaemia	0.007	0.993	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.007	0.993	0.000
C93.2 Subacute monocytic leukaemia	0.007	0.993	0.000
C93.0 Acute monocytic leukaemia	0.007	0.993	0.000
C83.0 Small cell (diffuse)	0.007	0.993	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.007	0.993	0.000
C86.4 Blastic NK-cell lymphoma	0.007	0.993	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.007	0.993	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.007	0.993	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.007	0.993	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.007	0.993	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.007	0.993	0.000
C88 Malignant immunoproliferative diseases	0.007	0.993	0.000
C91.1 Chronic lymphocytic leukaemia	0.007	0.993	0.000
C95.7 Other leukaemia of unspecified cell type	0.007	0.993	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.007	0.993	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.007	0.993	0.000
C95.0 Acute leukaemia of unspecified cell type	0.007	0.993	0.000
C94.7 Other specified leukaemias	0.006	0.993	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.006	0.993	0.000
C94.5 Acute myelofibrosis	0.006	0.993	0.000
C94.4 Acute panmyelosis	0.006	0.993	0.000
C94.3 Mast cell leukaemia	0.006	0.993	0.000
C94.2 Acute megakaryoblastic leukaemia	0.006	0.993	0.000
C94.1 Chronic erythraemia	0.006	0.993	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.006	0.993	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.006	0.993	0.000
C96.8 Histiocytic sarcoma	0.006	0.993	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.006	0.993	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.006	0.993	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.006	0.993	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.006	0.993	0.000
C96.3 True histiocytic lymphoma	0.006	0.993	0.000
C96.2 Malignant mast cell tumour	0.006	0.993	0.000
C96.1 Malignant histiocytosis	0.006	0.993	0.000
C96.0 Letterer-Siwe disease	0.006	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.994	0.006
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.006	0.994	0.000
C85.0 Lymphosarcoma	0.006	0.994	0.000
C95.9 Leukaemia, unspecified	0.006	0.994	0.000
C84.0 Mycosis fungoides	0.006	0.994	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.006	0.994	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.006	0.994	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.006	0.994	0.000
C84.3 Lymphoepithelioid lymphoma	0.006	0.994	0.000
C84.2 T-zone lymphoma	0.006	0.994	0.000
C84.1 Sezary's diease	0.006	0.994	0.000
C81.1 Nodular sclerosis	0.006	0.994	0.000
E10.9 Without complications	0.006	0.994	0.000
F60.9 Personality disorder, unspecified	0.000	0.994	0.006
C81.2 Mixed cellularity	0.006	0.994	0.000
F52.2 Failure of genital response	0.006	0.994	0.000
C81.7 Other Hodgkin's disease	0.006	0.994	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.006	0.994	0.000
C81.3 Lymphocytic depletion	0.006	0.994	0.000
C84.5 Other and unspecified T-cell lymphomas	0.006	0.994	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.994	0.006
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.994	0.006
C81.0 Lymphocytic predominance	0.005	0.994	0.000
C84.4 Peripheral T-cell lymphoma	0.005	0.995	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.005	0.995	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.005	0.995	0.000
C88.7 Other malignant immunoproliferative diseases	0.005	0.995	0.000
C88.3 Immunoproliferative small intestinal disease	0.005	0.995	0.000
C88.2 Gamma heavy chain disease	0.005	0.995	0.000
C88.1 Alpha heavy chain disease	0.005	0.995	0.000
H54.4 Blindness, one eye	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.995	0.005
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.004	0.995	0.001
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.004	0.995	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.995	0.005
C85.7 Other specified types of non-Hodgkin's lymphoma	0.004	0.995	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.005	0.995	0.000
H50.5 Heterophoria	0.000	0.996	0.004
S06.20 Diffuse brain injury (without open intracranial wound)	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
E10 Insulin-dependent diabetes mellitus	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.996	0.004
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.996	0.004
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.004
R07.0 Pain in throat	0.000	0.996	0.004
F52 Sexual dysfunction, not caused by organic disorder or disease	0.004	0.996	0.000
E10.1 With ketoacidosis	0.004	0.996	0.000
T86.8 Failure and rejection of other transplanted organs and tissues	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.004	0.996	0.000
C90.3 Solitary plasmacytoma	0.004	0.996	0.000
H50.0 Convergent concomitant strabismus	0.000	0.996	0.004
H54.0 Blindness, both eyes	0.004	0.996	0.000
C50.8 Overlapping lesion of breast	0.000	0.996	0.004
C90.2 Plasmacytoma, extramedullary	0.004	0.996	0.000
H59.0 Vitreous syndrome following cataract surgery	0.004	0.996	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.996	0.004
T43.6 Psychostimulants with abuse potential	0.000	0.996	0.004
E10.2 With renal complications	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.003	0.996	0.000
C82.0 Small cleaved cell, follicular	0.003	0.996	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.004	0.996	0.000
C82.6 Cutaneous follicle centre lymphoma	0.003	0.996	0.001
C82.5 Diffuse follicle centre lymphoma	0.003	0.996	0.001
C90.1 Plasma cell leukaemia	0.004	0.996	0.000
R47.1 Dysarthria and anarthria	0.000	0.996	0.004
C82.3 Follicular lymphoma grade IIIa	0.003	0.996	0.000
E10.4 With neurological complications	0.004	0.996	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.003	0.996	0.000
E10.6 With other specified complications	0.003	0.997	0.000
H50 Other strabismus	0.000	0.997	0.003
F52.0 Lack or loss of sexual desire	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
E10.3 With ophthalmic complications	0.003	0.997	0.000
E10.7 With multiple complications	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
S52.10 Fracture of upper end of radius (closed)	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.000	0.997	0.003
Z71.1 Person with feared complaint in whom no diagnosis is made	0.003	0.997	0.000
C82.2 Large cell, follicular	0.003	0.997	0.001
F60 Specific personality disorders	0.000	0.997	0.003
E10.5 With peripheral circulatory complications	0.003	0.997	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.003	0.997	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.003	0.997	0.000
F52.7 Excessive sexual drive	0.003	0.997	0.000
F52.6 Nonorganic dyspareunia	0.003	0.997	0.000
F52.5 Nonorganic vaginismus	0.003	0.997	0.000
F52.4 Premature ejaculation	0.003	0.997	0.000
F52.3 Orgasmic dysfunction	0.003	0.997	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.003	0.997	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.997	0.003
L85.8 Other specified epidermal thickening	0.000	0.997	0.003
I60 Subarachnoid haemorrhage	0.000	0.997	0.003
H50.8 Other specified strabismus	0.000	0.997	0.003
Z71.6 Tobacco abuse counselling	0.003	0.997	0.000
E10.0 With coma	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
G25.0 Essential tremor	0.000	0.997	0.003
M54.57 Low back pain (Lumbosacral region)	0.000	0.997	0.003
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.000	0.997	0.003
F60.3 Emotionally unstable personality disorder	0.000	0.997	0.003
C81.9 Hodgkin's disease, unspecified	0.003	0.997	0.000
N75.0 Cyst of Bartholin's gland	0.003	0.997	0.000
R45.8 Other symptoms and signs involving emotional state	0.000	0.997	0.003
E10.8 With unspecified complications	0.003	0.997	0.000
R59.9 Enlarged lymph nodes, unspecified	0.000	0.997	0.003
H50.3 Intermittent heterotropia	0.000	0.997	0.003
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.003	0.997	0.000
F51 Nonorganic sleep disorders	0.003	0.997	0.000
I60.8 Other subarachnoid haemorrhage	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.003	0.997	0.000
H50.6 Mechanical strabismus	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
Z71.2 Person consulting for explanation of investigation findings	0.003	0.997	0.000
H54 Blindness and low vision	0.003	0.997	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.997	0.003
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.003	0.997	0.000
F60.4 Histrionic personality disorder	0.000	0.997	0.003
F60.1 Schizoid personality disorder	0.000	0.997	0.003
T21.2 Burn of second degree of trunk	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
F60.6 Anxious [avoidant] personality disorder	0.000	0.997	0.003
I60.4 Subarachnoid haemorrhage from basilar artery	0.000	0.997	0.003
F60.2 Dissocial personality disorder	0.000	0.997	0.002
R82.9 Other and unspecified abnormal finding in urine	0.003	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.997	0.002
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.003	0.997	0.000
F60.8 Other specific personality disorders	0.000	0.997	0.002
H50.1 Divergent concomitant strabismus	0.000	0.997	0.003
F60.7 Dependent personality disorder	0.000	0.997	0.002
I60.5 Subarachnoid haemorrhage from vertebral artery	0.000	0.997	0.002
F51.4 Sleep terrors [night terrors]	0.002	0.997	0.000
Z71.4 Alcohol abuse counselling and surveillance	0.003	0.997	0.000
Z93.0 Tracheostomy status	0.003	0.997	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.997	0.000
K52.1 Toxic gastro-enteritis and colitis	0.003	0.997	0.000
F60.5 Anankastic personality disorder	0.000	0.997	0.002
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.997	0.002
S92.30 Fracture of metatarsal bone (closed)	0.000	0.997	0.002
F51.0 Nonorganic insomnia	0.002	0.997	0.000
H50.4 Other and unspecified heterotropia	0.000	0.997	0.002
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.998	0.000
F51.3 Sleepwalking [somnambulism]	0.002	0.998	0.000
H50.9 Strabismus, unspecified	0.000	0.998	0.002
H50.2 Vertical strabismus	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.000	0.998	0.002
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
A49.9 Bacterial infection, unspecified	0.002	0.998	0.000
S06.2 Diffuse brain injury	0.002	0.998	0.000
S70.1 Contusion of thigh	0.000	0.998	0.002
F51.9 Nonorganic sleep disorder, unspecified	0.002	0.998	0.000
F51.8 Other nonorganic sleep disorders	0.002	0.998	0.000
F51.5 Nightmares	0.002	0.998	0.000
F51.2 Nonorganic disorder of the sleep-wake schedule	0.002	0.998	0.000
F51.1 Nonorganic hypersomnia	0.002	0.998	0.000
H54.2 Low vision, both eyes	0.002	0.998	0.000
E05.5 Thyroid crisis or storm	0.002	0.998	0.000
E05.4 Thyrotoxicosis factitia	0.002	0.998	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.002	0.998	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.002	0.998	0.000
H11.0 Pterygium	0.000	0.998	0.002
D17.7 Benign lipomatous neoplasm of other sites	0.002	0.998	0.000
H54.5 Low vision, one eye	0.002	0.998	0.000
H54.3 Unqualified visual loss, both eyes	0.002	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.998	0.002
Z32.1 Pregnancy confirmed	0.000	0.998	0.002
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.002	0.998	0.000
F55 Abuse of non-dependence-producing substances	0.002	0.998	0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.002	0.998	0.000
R45.0 Nervousness	0.000	0.998	0.002
S51.9 Open wound of forearm, part unspecified	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
Z71.7 Human immunodeficiency virus [HIV] counselling	0.002	0.998	0.000
Z71.5 Drug abuse counselling and surveillance	0.002	0.998	0.000
Z71.0 Person consulting on behalf of another person	0.002	0.998	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.998	0.002
T21.3 Burn of third degree of trunk	0.000	0.998	0.002
F53.9 Puerperal mental disorder, unspecified	0.002	0.998	0.000
F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.998	0.000
F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.998	0.000
Z71.9 Counselling, unspecified	0.002	0.998	0.000
R84.5 Abnormal microbiological findings	0.000	0.998	0.002
R45 Symptoms and signs involving emotional state	0.000	0.998	0.002
T21 Burn and corrosion of trunk	0.000	0.998	0.002
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.002	0.998	0.000
G25.2 Other specified forms of tremor	0.000	0.998	0.002
Y84.0 Cardiac catheterisation	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
Z71.8 Other specified counselling	0.002	0.998	0.000
Z99.1 Dependence on respirator	0.002	0.998	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.002	0.998	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
H54.1 Blindness, one eye, low vision, other eye	0.002	0.998	0.000
R45.5 Hostility	0.000	0.998	0.002
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.002	0.998	0.000
N60.1 Diffuse cystic mastopathy	0.000	0.998	0.002
E05.8 Other thyrotoxicosis	0.002	0.998	0.000
O61.0 Failed medical induction of labour	0.000	0.998	0.002
T21.0 Burn of unspecified degree of trunk	0.000	0.998	0.002
F50 Eating disorders	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
I49.4 Other and unspecified premature depolarisation	0.002	0.998	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.998	0.002
F69 Unspecified disorder of adult personality and behaviour	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T86 Failure and rejection of transplanted organs and tissues	0.002	0.998	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.002	0.998	0.000
K52.3 Indeterminate colitis	0.002	0.998	0.000
R45.4 Irritability and anger	0.000	0.998	0.002
S70 Superficial injury of hip and thigh	0.000	0.998	0.002
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
I05.2 Mitral stenosis with insufficiency	0.000	0.998	0.002
W17.4 Street and highway	0.000	0.998	0.002
G93.3 Postviral fatigue syndrome	0.002	0.998	0.000
S70.8 Other superficial injuries of hip and thigh	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
N42.2 Atrophy of prostate	0.002	0.998	0.000
T86.0 Bone-marrow transplant rejection	0.002	0.998	0.000
F60-F69 Disorders of adult personality and behaviour	0.000	0.998	0.002
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.998	0.002
G40.8 Other epilepsy	0.002	0.998	0.000
O43.8 Other placental disorders	0.002	0.998	0.000
Q63.0 Accessory kidney	0.002	0.998	0.000
R45.2 Unhappiness	0.000	0.998	0.002
R45.1 Restlessness and agitation	0.000	0.998	0.002
K70.0 Alcoholic fatty liver	0.000	0.998	0.002
R45.3 Demoralisation and apathy	0.000	0.998	0.002
T21.7 Corrosion of third degree of trunk	0.000	0.998	0.002
T21.6 Corrosion of second degree of trunk	0.000	0.998	0.002
T21.5 Corrosion of first degree of trunk	0.000	0.998	0.002
T21.4 Corrosion of unspecified degree of trunk	0.000	0.998	0.002
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.002	0.998	0.000
K83.8 Other specified diseases of biliary tract	0.000	0.998	0.002
S52.1 Fracture of upper end of radius	0.002	0.998	0.000
G25 Other extrapyramidal and movement disorders	0.000	0.998	0.002
A49.2 Haemophilus influenzae infection, unspecified	0.002	0.998	0.000
H54.9 Unspecified visual impairment (binocular)	0.002	0.998	0.000
T21.1 Burn of first degree of trunk	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
C22.9 Liver, unspecified	0.000	0.998	0.002
N89.9 Noninflammatory disorder of vagina, unspecified	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.001
T37.5 Antiviral drugs	0.000	0.998	0.001
T37.4 Anthelminthics	0.000	0.998	0.001
T37.3 Other antiprotozoal drugs	0.000	0.998	0.001
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.001
T37.1 Antimycobacterial drugs	0.000	0.998	0.001
T37.0 Sulphonamides	0.000	0.998	0.001
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.000	0.998	0.002
O71.4 Obstetric high vaginal laceration alone	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.001
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.001
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.001
T44.0 Anticholinesterase agents	0.000	0.998	0.001
X60.8 Other specified place	0.002	0.998	0.000
M71.12 Other infective bursitis (Upper arm)	0.002	0.998	0.000
I12.0 Hypertensive renal disease with renal failure	0.002	0.998	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.998	0.001
S70.0 Contusion of hip	0.000	0.998	0.002
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.998	0.002
D30.3 Bladder	0.002	0.998	0.000
F50.8 Other eating disorders	0.001	0.998	0.000
F50.5 Vomiting associated with other psychological disturbances	0.001	0.998	0.000
F50.4 Overeating associated with other psychological disturbances	0.001	0.998	0.000
F50.3 Atypical bulimia nervosa	0.001	0.998	0.000
F50.1 Atypical anorexia nervosa	0.001	0.998	0.000
T41.5 Therapeutic gases	0.000	0.998	0.001
T41.4 Anaesthetic, unspecified	0.000	0.998	0.001
T41.3 Local anaesthetics	0.000	0.998	0.001
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.001
T41.1 Intravenous anaesthetics	0.000	0.998	0.001
T41.0 Inhaled anaesthetics	0.000	0.998	0.001
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.001
T48.5 Anti-common-cold drugs	0.000	0.998	0.001
T48.4 Expectorants	0.000	0.998	0.001
T48.3 Antitussives	0.000	0.998	0.001
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.001
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.001
T48.0 Oxytocic drugs	0.000	0.998	0.001
T49.9 Topical agent, unspecified	0.000	0.998	0.001
T49.8 Other topical agents	0.000	0.998	0.001
T49.7 Dental drugs, topically applied	0.000	0.998	0.001
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.001
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.001
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.001
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.001
T49.2 Local astringents and local detergents	0.000	0.998	0.001
T49.1 Antipruritics	0.000	0.998	0.001
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.001
T86.9 Failure and rejection of unspecified transplanted organ and tissue	0.001	0.998	0.000
T86.3 Heart-lung transplant failure and rejection	0.001	0.998	0.000
T86.2 Heart transplant failure and rejection	0.001	0.998	0.000
A49 Bacterial infection of unspecified site	0.002	0.998	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.998	0.002
C44.0 Skin of lip	0.002	0.998	0.000
H33.5 Other retinal detachments	0.002	0.998	0.000
S70.7 Multiple superficial injuries of hip and thigh	0.000	0.998	0.001
S92.3 Fracture of metatarsal bone	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.001
Z63.4 Disappearance and death of family member	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.001
L51.9 Erythema multiforme, unspecified	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.001
F50.9 Eating disorder, unspecified	0.001	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.001
Y57.9 Drug or medicament, unspecified	0.000	0.998	0.002
R82.4 Acetonuria	0.001	0.998	0.000
J69.0 Pneumonitis due to food and vomit	0.002	0.998	0.000
K60.5 Anorectal fistula	0.002	0.998	0.000
Q38.7 Pharyngeal pouch	0.000	0.998	0.001
F68 Other disorders of adult personality and behaviour	0.000	0.998	0.001
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.000	0.998	0.001
F65 Disorders of sexual preference	0.000	0.998	0.001
F63 Habit and impulse disorders	0.000	0.998	0.001
F61 Mixed and other personality disorders	0.000	0.998	0.001
S52.11 Fracture of upper end of radius (open)	0.001	0.998	0.000
T86.1 Kidney transplant failure and rejection	0.001	0.998	0.000
M77.02 Medial epicondylitis (Upper arm)	0.001	0.998	0.000
S52.01 Fracture of upper end of ulna (open)	0.000	0.998	0.001
C22.1 Intrahepatic bile duct carcinoma	0.000	0.998	0.001
G25.9 Extrapyramidal and movement disorder, unspecified	0.000	0.998	0.001
G25.6 Drug-induced tics and other tics of organic origin	0.000	0.998	0.001
G25.4 Drug-induced chorea	0.000	0.998	0.001
H26.1 Traumatic cataract	0.001	0.998	0.000
M31.6 Other giant cell arteritis	0.000	0.998	0.002
R45.6 Physical violence	0.000	0.998	0.001
X62.9 Unspecified place	0.001	0.998	0.000
G25.3 Myoclonus	0.000	0.999	0.001
H61.2 Impacted cerumen	0.000	0.999	0.001
R45.7 State of emotional shock and stress, unspecified	0.000	0.999	0.001
T82.0 Mechanical complication of heart valve prosthesis	0.001	0.999	0.000
F50.2 Bulimia nervosa	0.001	0.999	0.000
G71.1 Myotonic disorders	0.000	0.999	0.001
J01.9 Acute sinusitis, unspecified	0.000	0.999	0.001
F50.0 Anorexia nervosa	0.001	0.999	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.999	0.001
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.000	0.999	0.001
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.001	0.999	0.000
S92.31 Fracture of metatarsal bone (open)	0.000	0.999	0.001
A49.3 Mycoplasma infection, unspecified	0.001	0.999	0.000
I34.1 Mitral (valve) prolapse	0.000	0.999	0.001
T86.4 Liver transplant failure and rejection	0.001	0.999	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.001	0.999	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.000	0.999	0.001
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.999	0.001
M62.89 Other specified disorders of muscle (Site unspecified)	0.000	0.999	0.001
A49.0 Staphylococcal infection, unspecified	0.001	0.999	0.000
C50.2 Upper-inner quadrant of breast	0.000	0.999	0.001
G54.9 Nerve root and plexus disorder, unspecified	0.000	0.999	0.001
R82 Other abnormal findings in urine	0.001	0.999	0.000
D37.0 Lip, oral cavity and pharynx	0.001	0.999	0.000
G25.5 Other chorea	0.000	0.999	0.001
H60.9 Otitis externa, unspecified	0.001	0.999	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.999	0.001
T36.8 Other systemic antibiotics	0.000	0.999	0.001
T36.7 Antifungal antibiotics, systemically used	0.000	0.999	0.001
T36.6 Rifamycins	0.000	0.999	0.001
T36.5 Aminoglycosides	0.000	0.999	0.001
T36.4 Tetracyclines	0.000	0.999	0.001
T36.2 Chloramphenicol group	0.000	0.999	0.001
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.999	0.001
T45.5 Anticoagulants	0.000	0.999	0.001
B37 Candidiasis	0.000	0.999	0.001
F64 Gender identity disorders	0.000	0.999	0.001
C67.4 Posterior wall of bladder	0.001	0.999	0.000
G25.1 Drug-induced tremor	0.000	0.999	0.001
S32.7 Multiple fractures of lumbar spine and pelvis	0.000	0.999	0.001
Z45.1 Adjustment and management of infusion pump	0.000	0.999	0.001
A49.1 Streptococcal infection, unspecified	0.001	0.999	0.000
F63.9 Habit and impulse disorder, unspecified	0.000	0.999	0.001
F63.8 Other habit and impulse disorders	0.000	0.999	0.001
F63.3 Trichotillomania	0.000	0.999	0.001
F63.2 Pathological stealing [kleptomania]	0.000	0.999	0.001
F63.1 Pathological fire-setting [pyromania]	0.000	0.999	0.001
F63.0 Pathological gambling	0.000	0.999	0.001
F65.9 Disorder of sexual preference, unspecified	0.000	0.999	0.001
F65.8 Other disorders of sexual preference	0.000	0.999	0.001
F65.6 Multiple disorders of sexual preference	0.000	0.999	0.001
F65.5 Sadomasochism	0.000	0.999	0.001
F65.4 Paedophilia	0.000	0.999	0.001
F65.3 Voyeurism	0.000	0.999	0.001
F65.2 Exhibitionism	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations